'At-risk' for psychosis research: Where are we heading?

Epidemiology and Psychiatric Sciences

Volumn 21, Issue 4, 2012, Pages 329-334

  Lin, A ^a   Nelson, B ^b   Yung, A R ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Non psychotic disorders; outcomes; prodrome; psychosis; UHR

Indexed keywords

CLINICAL HIGH RISK; GENETIC RISK; HUMAN; MEDICAL HISTORY; NEUROBIOLOGY; OUTCOME ASSESSMENT; PERSONALITY DISORDER; PREDICTION; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; ULTRA HIGH RISK;

HUMANS; MENTAL DISORDERS; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK; RISK FACTORS;

EID: 84869400543     PISSN: 20457960     EISSN: 20457979     Source Type: Journal    
DOI: 10.1017/S2045796012000388     Document Type: Review

References (36)

1. Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R (2011). At clinical high risk for psychosis: outcome for nonconverters. American Journal of Psychiatry 168, 800-805.
2. Carpenter WT, Heinrichs DW, Wagman AMI (1988). Deficit and nondeficit forms of schizophrenia: the concept. American Journal of Psychiatry 145, 578-583.
3. Corcoran C, Kimhy D, Parrilla-Escobar M, Cressman V, Stanford A, Thompson J, David SB, Crumbley A, Schobel S, Moore H, Malaspina D (2011). The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychological Medicine 41, 251.
4. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E (2003). The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophrenia Bulletin 29, 633-651. (Pubitemid 38181947)
5. Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T (2011). Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin, doi:10.1093/schbul/sbr136.
6. Correll CU, Hauser M, Auther AM, Cornblatt BA (2010). Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry 51, 390-431.
7. Fenton WS, McGlashan TH (1994). Antecedents, symptom progression, and long-term outcome of deficit syndrome schizophrenia. American Journal of Psychiatry 151, 351-356. (Pubitemid 24081452)
8. Fusar-oli P, Bonoldi I, Yung AR, Borgwardt SJ, Kempton M, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012). Predicting psychosis: meta-analysis of evidence of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 69, 220-229.
9. Häfner H, Löffler W, Maurer K, Hambrecht M, an der Heiden W (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica 100, 105-118. (Pubitemid 29372527)
10. Haroun N, Dunn L, Haroun A, Cadenhead KS (2006). Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin 32, 166-178. (Pubitemid 43063832)
11. Iyer SN, Boekestyn L, Cassidy CM, King S, Joober R, Malla AK (2008). Signs and symptoms in the pre-sychotic phase: description and implications for diagnostic trajectories. Psychological Medicine 38, 1147-1156. (Pubitemid 351950151)
12. Lam M, Hung S, Chen E (2006). Transition to psychosis: 6-month follow-up of a Chinese high-risk group in Hong Kong. Australian and New Zealand Journal of Psychiatry 40, 414-420.
13. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B (2004). Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research 68, 37-48. (Pubitemid 38368135)
14. Lin A, Wood SJ, Nelson B, Brewer WJ, Spiliotacopoulos D, Bruxner A, Broussard C, Pantelis C, Yung AR (2011). Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophrenia Research 132, 1-7.
15. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V (2004). Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'. Schizophrenia Research 71, 227-237. (Pubitemid 39330501)
16. McGorry P, Yung A, Phillips L, Yuen H, Francey S, Cosgrave E, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry 59, 921-928.
17. Miller TJ, McGlashan TH, Rosen J, Cadenhead K, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003). Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703-715. (Pubitemid 38181951)
18. Piskulic D, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, McGlashan TH (2012). Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Research 196, 220-224.
19. Raine A (2006). Schizotypal personality: neurodevelopmental and psychosocial trajectories. Clinical Psychology 2, 291-326. (Pubitemid 43799807)
20. Riecher-Rössler A, Gschwandtner U, Aston J, Borgwardt S, Drewe M, Fuhr M, Pflüger M, Radü W, Schindler Ch, Stieglitz RD (2007). The Basel early-detection-of-sychosis (FEPSY)-study design and preliminary results. Acta Psychiatrica Scandinavica 115, 114-125. (Pubitemid 46114872)
21. Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2003). Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 3, 162-167.
22. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L (2011). Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophrenia Research 132, 8-17.
23. Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, Wojcik J, Kelleher JP, Green AI (1999). Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies. Biological Psychiatry 45, 1412-1418. (Pubitemid 29457552)
24. Tsuang MT, Stone WS, Tarbox SI, Faraone SV (2002a). An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophrenia Research 54, 169-175. (Pubitemid 34164531)
25. Tsuang MT, Stone WS, Tarbox SI, Faraone SV (2002b). Treatment of nonpsychotic relatives of patients with schizophrenia: six case studies. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 114, 943-948. (Pubitemid 35379238)
26. Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH (2009). Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis. Schizophrenia Research 109, 60-65.
27. Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkötter J, Ruhrmann S (2010). Disability in people clinically at high risk of psychosis. British Journal of Psychiatry 197, 278-284.
28. Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH (2009). Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 35, 894-908.
29. World Health Organization (1994). International Statistical Classification of Diseases and Related Health Problems, 10th rev. WHO: Geneva.
30. Yung A, McGorry PD (1996). The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin 22, 353-370. (Pubitemid 26174579)
31. Yung A, McGorry PD, McFarlane CA, Jackson H, Patton GC, Rakkar A (1996). Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin 22, 283-303. (Pubitemid 26174575)
32. Yung A, Phillips L, Yuen H, McGorry P (2004). Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophrenia Research 67, 131-142. (Pubitemid 38251443)
33. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003). Psychosis prediction: 12-month follow up of a high-risk. Schizophrenia Research 60, 21-32.
34. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005). Mapping the onset of psychosis: the Comprehensive Assessment of At Risk Mental States. Australian and New Zealand Journal of Psychiatry 39, 964-971. (Pubitemid 43904432)
35. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P (2007). Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophrenia Bulletin 33, 673-681. (Pubitemid 47343718)
36. Yung AR, Nelson B, Thompson A, Wood SJ (2010). The psychosis threshold in Ultra High Risk (prodromal) research: is it valid? Schizophrenia Research 120, 1-6.